Silence Therapeutics

SLNNasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$559.260 M

$11.95 +1.96%

Close of 7 Aug 2026

Revenue

$559.0K

#3550 by revenue

Earnings

-$88.6M

Loss-making

Shares outstanding

141,703,840

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#201Contineum TherapeuticsCTNM$565.8M
#202Sagimet BiosciencesSGMT$559.5M
#203Silence TherapeuticsSLN$559.3M
#204Shattuck LabsSTTK$557.5M
#205MapLight TherapeuticsMPLT$551.9M

Where these numbers come from

Share counts and financials for Silence Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.